Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1983
Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats
R W Fuller, S K Hemrick-Luecke, D T Wong, et al.
NIDA Research Monograph
|
February 1, 1981
Preclinical pharmacology of doxpicodin, a new analgesic
S E Smits, R Nickander, R N Booher, et al.
Drug and Alcohol Dependence
|
February 1, 1985
Picenadol
D M Zimmerman, S E Smits, M D Hynes, et al.
The Journal of the American Board of Family Practice
|
June 6, 1998
Computerized prompts for cancer screening in a community health center
K S Yarnall, B K Rimer, D Hynes, et al.
Orthopedics
|
May 29, 2000
An investigation into the role of oxygen free radical scavengers in preventing polymethylmethacrylate-induced necrosis in an osteoblast cell culture
J G Kennedy, P O'Grady, D R McCarthy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1989
Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist
M M Foreman, R W Fuller, M D Hynes, et al.
Life Sciences
|
March 12, 1984
Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl) indole (DPAI)
J A Clemens, R W Fuller, L A Phebus, et al.
Journal of Medicinal Chemistry
|
August 1, 1983
Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline
R D Titus, E C Kornfeld, N D Jones, et al.
Nature Medicine
|
April 19, 2022
Development of a clinical polygenic risk score assay and reporting workflow
Limin Hao, Peter Kraft, Gabriel F Berriz, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1983
Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats
R W Fuller, S K Hemrick-Luecke, D T Wong, et al.
NIDA Research Monograph
|
February 1, 1981
Preclinical pharmacology of doxpicodin, a new analgesic
S E Smits, R Nickander, R N Booher, et al.
Drug and Alcohol Dependence
|
February 1, 1985
Picenadol
D M Zimmerman, S E Smits, M D Hynes, et al.
The Journal of the American Board of Family Practice
|
June 6, 1998
Computerized prompts for cancer screening in a community health center
K S Yarnall, B K Rimer, D Hynes, et al.
Orthopedics
|
May 29, 2000
An investigation into the role of oxygen free radical scavengers in preventing polymethylmethacrylate-induced necrosis in an osteoblast cell culture
J G Kennedy, P O'Grady, D R McCarthy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1989
Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist
M M Foreman, R W Fuller, M D Hynes, et al.
Life Sciences
|
March 12, 1984
Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl) indole (DPAI)
J A Clemens, R W Fuller, L A Phebus, et al.
Journal of Medicinal Chemistry
|
August 1, 1983
Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline
R D Titus, E C Kornfeld, N D Jones, et al.
Nature Medicine
|
April 19, 2022
Development of a clinical polygenic risk score assay and reporting workflow
Limin Hao, Peter Kraft, Gabriel F Berriz, et al.
Page
of 7